Q/C Technologies, Inc. (QCLS)
NASDAQ: QCLS · Real-Time Price · USD
4.180
-0.340 (-7.52%)
At close: Oct 21, 2025, 4:00 PM EDT
4.280
+0.100 (2.39%)
After-hours: Oct 21, 2025, 7:42 PM EDT
Q/C Technologies Employees
Q/C Technologies had 2 employees as of December 31, 2024. The number of employees decreased by 4 or -66.67% compared to the previous year.
Employees
2
Change (1Y)
-4
Growth (1Y)
-66.67%
Revenue / Employee
n/a
Profits / Employee
-$5,263,563
Market Cap
12.45M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2 | -4 | -66.67% |
Dec 31, 2023 | 6 | -3 | -33.33% |
Dec 31, 2022 | 9 | 0 | - |
Dec 31, 2021 | 9 | 3 | 50.00% |
Dec 31, 2020 | 6 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Microsoft | 228,000 |
Apple | 164,000 |
Oracle | 162,000 |
SAP SE | 109,973 |
Cisco Systems | 86,200 |
Taiwan Semiconductor Manufacturing Company | 83,825 |
ASML Holding | 44,027 |
Broadcom | 37,000 |
QCLS News
- 5 days ago - Q/C Technologies Appoints Technion Professor Dr. Steven Frankel as Senior Quantum Advisor to Advance Photonic and Quantum-Class Computing Initiatives - GlobeNewsWire
- 26 days ago - Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS” - Business Wire
- 27 days ago - TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing - Business Wire
- 4 weeks ago - TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement - Business Wire
- 6 weeks ago - TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Business Wire
- 6 weeks ago - TNF Pharmaceuticals Announces Closing of $7 Million Private Placement - Business Wire
- 7 weeks ago - PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications - Business Wire
- 7 weeks ago - TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications - Business Wire